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Abstract: 
Objective: Determine the diagnostic accuracy of visual inspection of cervix (VIA) by using 3% acetic acid as a 
screening test for early and timely detection of cervical cancer when histopathology taken as the gold standard of 
diagnosis. Methodology: This study was conducted at Nishtar  Hospital, Multan, and the study design choose 
for conducting this study was Cross Sectional study method. Study was completed in one year duration from 
February 2018 to February 2019. All statistical data was entered and analyzed by using SPSS version 23. 
Frequencies and percentages were calculated and presented for qualitative variables like marital status. Parity, 
ethnic group and religion. Mean ± Standard Deviation (SD) was calculated for numerical variables like duration 
of marriage and age. The diagnostic accuracy, sensitivity specificity and positive predictive value (PPV) and 
negative predictive value (NPV) was calculated using two into two contingency table and histopathology was 
taken as the gold standard. Results: Overall, 100% (n=320) female patients were included, in this study. There 
were 87.2% (n=279) patients had poor socio-economic status, while 12.8% (n=41) had good socio-economic 
status. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of VIA and 
abnormal looking cervix were 81.7%, 80.7%, 51.5%, 48.5% and 81.3% respectively. Conclusion: Screening 
schedules are not planned and followed in Pakistan ever, so VIA is effective and always a useful diagnostic test 
for cervical cancer, pre-cancerous lesions can be detected at their early stage through VIA and mortality and 
morbidity can be reduced. 
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Introduction: 
In developing countries incidence of cervical cancer is more common among women1, 2. Every year more than 
490,000 cases of cervical cancer appear all over the world in developing countries3. There are many diagnostic 
tests to diagnose the disease at early stage to start early treatment to decrease the mortality rate3. Disease control 
rate is increased through screening process; out of many diagnostic tests PAP smear test is one of the effective 
screening method to diagnose Cervical Cancer4.  
One of the limitation of this test is, it is not easily available in under developed countries like Pakistan due to 
lack of Economical Resources5. Many other low cost diagnostic techniques are likely been used to investigate 
such problems in low income countries like Visual Inspection of Cervix after applying Acetic Acid (VIA), 
Visual inspection after lugol’s iodine (VILI)6. Visual Inspection of Cervix after applying Acetic Acid is an 
effective method of differentiating healthy Cervix from non-healthy of diseased Cervix7.  
According to WHO Visual inspection after applying Acetic Acid Test technique can be used as a substitute of 
PAP smear cytology for identifying the cervical cancer patients6. Visual Inspection of Cervix after applying 
Acetic Acid (VIA) test is a non-invasive test which gives immediate reporting. Due to this specificity this test 
can be easily perform to diagnose Cervical Cancer in developing Countries like Pakistan5. 
Diagnostic Results through PAP smear and VIA has almost same diagnostic results but still it is under process 
that which screening test should be use as primary screening method to diagnose Cervical Cancer9. Other than 
cervical cancer dysplasia is also an abnormal appearance of cervix but it is not cancer, it can also be diagnosed 
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with Pap smear test. Dysplasia may be precancerous presentation of cervix. Another common pre-cancerous 
presentation is cervical intraepithelial neoplasia and can be diagnosed by biopsy test of cervix. Treatment of 
these two presentations (SIL and CIN) is usual and can stop the development of cancer. Aim of this study is to 
find out the cost effective diagnostic test which can be use as primary screening test to diagnose Cervical Cancer. 
Methodology: 
This study was conducted at Nishtar Hospital, Multan, and the study design choose for conducting this study was 
Cross Sectional study method. Study was completed in one year duration from February 2018 to February 2019. 
After getting Ethical approval study was started in Gynaecology and obstetrical ward of hospital. Females of 
reproductive age 18-60 years were studied after taking informed consent from study population. Medical history 
was taken in detailed way and then Physical examination session was also arranged to assess the Cervix by 
trained staff. Separate room was arranged for maintaining privacy standards of the study personnel’s. Procedure 
was explained to the personnel’s to reduce their anxiety level. Sample size was calculated openepi.com by using 
CI 95%, power of study 80% and diagnostic accuracy 95.6%.  
Patients were positioned in Lithotomy position for Physical Examination of Cervix. Proper light stand was 
arranged in the examination room to make the inspection area visible. Acetic Acid swab was applied to the 
Cervix and then cervix area was observed for Acetowhite changes. Changes were noticed in duration of 1 
minute. In Diagnostic labeling Acetowhite changes were considered as Positive Test and dull or no changes were 
considered as negative test for diagnosing Cervical Cancer. 
Tissue Biopsy was taken from the positive diagnostic results personnel’s and the samples were sent to 
histopathology lab for further investigation. To analyze the frequencies and percentages all the data was 
analyzed in SPSS-17. Categorical variables were formed on the basis of Age, Marital Status, religion and ethnic 
group. Sensitivity and the specificity of the diagnostic test were calculated according to positive predictive value 
and negative predictive value. 
All statistical data was entered and analyzed by using SPSS version 23. Frequencies and percentages were 
calculated and presented for qualitative variables like marital status. Parity, ethnic group and religion. Mean ± 
Standard Deviation (SD) was calculated for numerical variables like duration of marriage and age. The 
diagnostic accuracy, sensitivity specificity and positive predictive value (PPV) and negative predictive value 
(NPV) was calculated using two into two contingency table and histopathology was taken as the gold standard. 
Results: 
 Overall, 100% (n=320) female patients were included, in this study. There were 87.2% (n=279) patients 
had poor socio-economic status, while 12.8% (n=41) had good socio-economic status. Nulliparous women were 
8.8% (n=28), 47.1% (n=151) were single or multiparous, while 44.1% (n=141) were grand multipara. The mean 
age of the patients was 33.14±7.15 years. There were 36.9% (n=118) patients between 18-30 years, while 
majority of the patients i.e. 63.1% (n=202) between 31-50 years of age. (Table. 1). 
 The mean duration of sexual activity, menarche, age at first coitus, age at first pregnancy and parity of 
the patients was 12.04±5.81 years, 11.1±0.65 years, 17.16±2.44 years, 18.90±1.66 years and 5.03±1.15 
respectively. Vaginal discharge was observed in 54.7% (n=175) patients. While lower abdominal pain was noted 
in 40.6% (n=130) patients. (Table. 2). 
Among VIA positive patients in which cervixes looking abnormal 134 (51.5%) have positive histopathologic 
finding and 126 (48.5%) have negative histopathology, similarly among VIA negative and abnormal looking 
patients 30 (50%) patients have positive and 30 (50%) have negative histopathology (Table-3). 
 The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of VIA 
and abnormal looking cervix were 81.7%, 80.7%, 51.5%, 48.5% and 81.3% respectively (Table. 4). 
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Table-1: Demographic Variables 
 
 
 
 
  
 
 
 
 
 
 
 
Table-2: Frequencies of Study Variables  
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics Frequency Percentage (%) 
Socio-economic Status 
Poor  279 87.2 
Good 41 12.8 
Total 320 100.0 
Woman type 
Nulliparous 28 8.8 
Single or multiparous 151 47.1 
Grand multipara 141 44.1 
Total 320 100.0 
Stratified Age 
18-30 Years 118 36.9 
31-50 Years 202 63.1 
Total 320 100.0 
Descriptive Statistics (Mean±S.D) 
Age 33.14±7.15 years 
Characteristics Frequency Percentage (%) 
Vaginal Discharge 
Yes 175 54.7 
No 145 45.3 
Total 320 100.0 
Lower Abdominal Pain 
Yes 130 40.6 
No 190 59.4 
Total 320 100.0 
Descriptive Statistics (Mean±S.D) 
Duration of Sexual 
Activity 
12.04±5.81 years 
Menarche 11.1±0.65 years 
Age at first coitus 17.16±2.44 years 
Age at first pregnancy 18.90±1.66 years 
Parity 5.03±1.15 
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Table. 3: Validity of screening test for early diagnosis of cervical cancer 
VIA* Histopathology findings 
Positive Negative Total 
VIA Positive and 
Abnormal looking 
cervix 134 (51.5%) 126 (48.5%) 260 
VIA Negative but 
abnormal looking 
cervix 30 (50%) 30 (50%) 60 
Total 164 156 320 
*VIA: Visual inspection of the cervix after acetic acid application 
 
Table-4: Diagnostic Accuracy of VIA 
Diagnostic Measures  Value 
Sensitivity 81.7% 
Specificity 80.7% 
Positive Predictive Value (PPV) 51.5% 
Negative Predictive Value (PPV) 48.5% 
Accuracy 81.3% 
 
Discussion: 
Cervical Cancer is considered as one of the emerging health problem among females of reproductive age (10). 
Every year thousands of cases appear. Its incidence is higher in the developing countries like Pakistan (10). In 
Pakistan its incidence is about 3.6% in every year. The most dangerous thing is, people have less awareness 
about cervical cancer, due to lack of awareness about disease sign and symptoms patients come late to the 
hospitals specially they approach hospitals at last stages (11). 
Different diagnostic tests are performed to diagnose Cervical Cancers. The Diagnostic Test PAP Smear is the 
most common test in developed countries and can be use as primary diagnostic test for Cervical Cancer 
Screening in developed Countries, but in under developed countries due to lack of resources this test cannot be 
use commonly, so this test is not approachable in rural areas and under developed places (12). While Visual 
Inspection of Cervix after applying Acetic Acid (VIA) Test is use as a substitute of PAP smear in developing 
countries (13,14). 
In our study VIA was positive in 81.2% patients and among VIA positive patients in which cervixes looking 
abnormal 134 (51.5%) have positive histopathologic finding and 126 (48.5%) have negative histopathology, 
similarly among VIA negative and abnormal looking patients 30 (50%) patients have positive and 30 (50%) have 
negative histopathology. In some previous studies VIA positive was reported in 1.7 to 29% patients (15, 16, 17). 
VIA is a non-invasive test which provide quick results or it is less costly test. So it is a very useful test in 
developing countries to diagnose Cervical Cancer. This test can easily be performed in rural areas where 
hospitals do not have so many diagnostic resources. Due to its non-invasive approach this test can be perform 
easily without creating anxiety to patient.  Reporting of this test is quick and based on visual assessment; this 
property encourages quick diagnosis of Cervical Cancer. 
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According to one study 3.1 % females were diagnosed positive for Cervical Cancer through VIA testing on 
Acetowhite appearance of Cervix (18).  Another study was conducted, which showed that 28% females 
diagnosed as positive for Cervical Cancer over Acetowhite grading through VIA (19). 
In our study sensitivity, specificity, positive predictive value, negative predictive value and accuracy of VIA and 
abnormal looking cervix were 81.7%, 80.7%, 51.5%, 48.5% and 81.3% respectively. In some previous studies 
sensitivity of VIA noted from 60% to 100% and specificity ranged from 36.4% to 99.1% (20,21). 
Conclusion: Screening schedules are not planned and followed in Pakistan ever, so VIA is effective and always 
a useful diagnostic test for cervical cancer, pre-cancerous lesions can be detected at their early stage through 
VIA and mortality and morbidity can be reduced. 
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